Literature DB >> 9737804

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

H B Mortensen1, K J Robertson, H J Aanstoot, T Danne, R W Holl, P Hougaard, J A Atchison, F Chiarelli, D Daneman, B Dinesen, H Dorchy, P Garandeau, S Greene, H Hoey, E A Kaprio, M Kocova, P Martul, N Matsuura, E J Schoenle, O Søvik, P G Swift, R M Tsou, M Vanelli, J Aman.   

Abstract

Insulin regimens and metabolic control in children and adolescents with Type 1 diabetes mellitus were evaluated in a cross-sectional, non-population-based investigation, involving 22 paediatric departments, from 18 countries in Europe, Japan, and North America. Blood samples and information were collected from 2873 children from March to August 1995. HbA1c was determined once and analysed centrally (normal range 4.4-6.3%, mean 5.4%). Year of birth, sex, duration of diabetes, height, body weight, number of daily insulin injections, types and doses of insulin were recorded. Average HbA1c in children under 11 years was 8.3 +/- 1.3% (mean +/- SD) compared with 8.9 +/- 1.8% in those aged 12-18 years. The average insulin dose per kg body weight was almost constant (0.65 U kg(-1) 24 h(-1)) in children aged 2-9 years for both sexes, but there was a sharp increase during the pubertal years, particularly in girls. The increase in BMI of children with diabetes was much faster during adolescence compared to healthy children, especially in females. Sixty per cent of the children (n = 1707) used two daily insulin injections while 37% (n = 1071) used three or more. Of those on two or three injections daily, 37% used pre-mixed insulins, either alone or in combination with short- and intermediate-acting insulin. Pre-adolescent children on pre-mixed insulin showed similar HbA1c levels to those on a combination of short- and long-acting insulins, whereas in adolescents significantly better HbA1c values were achieved with individual combinations. Very young children were treated with a higher proportion of long-acting insulin. Among adolescent boys, lower HbA1c was related to use of more short-acting insulin. This association was not found in girls. We conclude that numerous insulin injection regimens are currently used in paediatric diabetes centres around the world, with an increasing tendency towards intensive diabetes management, particularly in older adolescents. Nevertheless, the goal of near normoglycaemia is achieved in only a few.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737804     DOI: 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  31 in total

1.  Assessment of an illness-specific dimension of self-esteem in youths with type 1 diabetes.

Authors:  Stefan Schneider; Ronald J Iannotti; Tonja R Nansel; Denise L Haynie; Douglas O Sobel; Bruce Simons-Morton
Journal:  J Pediatr Psychol       Date:  2008-07-29

2.  Caregiver reports of provider recommended frequency of blood glucose monitoring and actual testing frequency for youth with type 1 diabetes.

Authors:  Joyce P Yi-Frazier; Korey Hood; Doug Case; Beth Waitzfelder; Andrea Anderson; Clifford A Bloch; Michelle Naughton; Michael Seid; Giuseppina Imperatore; Beth Loots; Ronny Bell; Jean M Lawrence
Journal:  Diabetes Res Clin Pract       Date:  2011-09-21       Impact factor: 5.602

Review 3.  Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.

Authors:  David C Klonoff; Irina Nayberg; Udo Stauder; Hamid Oualali; Catherine Domenger
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

4.  Nationwide cross-sectional survey of 3560 children and adolescents with diabetes in Italy.

Authors:  M Vanelli; F Cerutti; F Chiarelli; R Lorini; F Meschi
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

5.  Depression and parenting in youth with type 1 diabetes: Are general and diabetes-specific parenting behaviors associated with depressive symptoms over a 2-year period?

Authors:  Katherine W Dempster; Aiyi Liu; Tonja R Nansel
Journal:  J Behav Med       Date:  2019-01-29

6.  Efficacy of Thrice-daily versus Twice-daily Insulin Regimens on Glycohemoglobin (Hb A1c) in Type 1 Diabetes Mellitus: A Randomized Controlled Trial.

Authors:  Zahra Razavi; Mehran Ahmadi
Journal:  Oman Med J       Date:  2011-01

7.  Long-term glycemic control as a result of initial education for children with new onset type 1 diabetes: does the setting matter?

Authors:  Susanne M Cabrera; Nayan T Srivastava; Jennifer M Behzadi; Tina M Pottorff; Linda A Dimeglio; Emily C Walvoord
Journal:  Diabetes Educ       Date:  2013-02-20       Impact factor: 2.140

8.  Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade.

Authors:  E-M Gerstl; W Rabl; J Rosenbauer; H Gröbe; S E Hofer; U Krause; R W Holl
Journal:  Eur J Pediatr       Date:  2007-10-09       Impact factor: 3.183

9.  Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.

Authors:  T Danne; T Battelino; P Jarosz-Chobot; O Kordonouri; E Pánkowska; J Ludvigsson; E Schober; E Kaprio; T Saukkonen; M Nicolino; N Tubiana-Rufi; C Klinkert; H Haberland; A Vazeou; L Madacsy; D Zangen; V Cherubini; I Rabbone; S Toni; C de Beaufort; W Bakker-van Waarde; N van den Berg; I Volkov; R Barrio; R Hanas; U Zumsteg; B Kuhlmann; C Aebi; U Schumacher; S Gschwend; P Hindmarsh; M Torres; N Shehadeh; M Phillip
Journal:  Diabetologia       Date:  2008-07-01       Impact factor: 10.122

10.  Family-based psychoeducation and Care Ambassador intervention to improve glycemic control in youth with type 1 diabetes: a randomized trial.

Authors:  Michelle L Katz; Lisa K Volkening; Deborah A Butler; Barbara J Anderson; Lori M Laffel
Journal:  Pediatr Diabetes       Date:  2013-08-05       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.